Coinfection of viruses in children with community-acquired pneumonia.
Children
Coinfection
Community-acquired pneumonia
Virus
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
16 Jul 2024
16 Jul 2024
Historique:
received:
23
10
2023
accepted:
10
07
2024
medline:
17
7
2024
pubmed:
17
7
2024
entrez:
16
7
2024
Statut:
epublish
Résumé
Virus, particularly respiratory tract virus infection is likely to co-occur in children with community-acquired pneumonia (CAP). Study focusing on the association between common viruses coinfection and children with CAP is rare. We aimed to study the association between seven common viruses coinfection and clinical/laboratory indexes in children with CAP. Six hundred and eighty-four CAP cases from our hospital were enrolled retrospectively. Seven common viruses, including influenza A (FluA), influenza B (FluB), human parainfluenza virus (HPIV), Esptein-Barr virus (EBV), coxsackie virus (CoxsV), cytomegalovirus (CMV), and herpes simplex virus (HSV) were investigated for their associations with CAP. We analyzed the differences of hospitalization days, white blood cell (WBC), c-reactive protein (CRP), platelet (PLT), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), urine red blood cell (uRBC), blood urea nitrogen (BUN), serum creatinine (Scr), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK) and creatine kinase isoenzyme (CKMB) among different viruses coinfection groups by using one-way ANOVA analysis. The differences of clinical/laboratory indexes between ordinary and severe pneumonia groups, as well as non-virus vs multi co-infection viruses groups, and single vs multi co-infection viruses groups by using independent samples T test. Receiver operating characteristic (ROC) curve analyses were applied to test the the predictive value of the clinical/laboratory parameters for the risk of viruses coinfections among CAP. Binary logistic analysis was performed to test the association between various indexes and viruses co-infection. Eighty-four multiple viruses coinfections yielded different prognosis compared with that in 220 single virus coinfection. CMV coinfection was associated with longest hospitalization days, highest ALT, AST and CKMB level. HSV coinfection was associated with highest WBC count, CRP, ESR, and BUN. EBV coinfection was associated with highest PLT and PCT level. FluB coinfection was associated with highest Scr level. CoxsV coinfection was associated with highest uRBC, LDH and CK level. ROC curve analyses showed that CK had the largest area under the curve (AUC: 0.672, p < 10 Multiple viruses coinfections indicated different prognosis. Different viruses coinfection yielded varying degrees of effects on the cardiac, liver, kidney and inflamatory injury in CAP. The alterations of clinical/laboratory parameters, particularly CK may be associated with the risk of viruses coinfections in CAP.
Sections du résumé
BACKGROUND
BACKGROUND
Virus, particularly respiratory tract virus infection is likely to co-occur in children with community-acquired pneumonia (CAP). Study focusing on the association between common viruses coinfection and children with CAP is rare. We aimed to study the association between seven common viruses coinfection and clinical/laboratory indexes in children with CAP.
METHODS
METHODS
Six hundred and eighty-four CAP cases from our hospital were enrolled retrospectively. Seven common viruses, including influenza A (FluA), influenza B (FluB), human parainfluenza virus (HPIV), Esptein-Barr virus (EBV), coxsackie virus (CoxsV), cytomegalovirus (CMV), and herpes simplex virus (HSV) were investigated for their associations with CAP. We analyzed the differences of hospitalization days, white blood cell (WBC), c-reactive protein (CRP), platelet (PLT), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), urine red blood cell (uRBC), blood urea nitrogen (BUN), serum creatinine (Scr), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK) and creatine kinase isoenzyme (CKMB) among different viruses coinfection groups by using one-way ANOVA analysis. The differences of clinical/laboratory indexes between ordinary and severe pneumonia groups, as well as non-virus vs multi co-infection viruses groups, and single vs multi co-infection viruses groups by using independent samples T test. Receiver operating characteristic (ROC) curve analyses were applied to test the the predictive value of the clinical/laboratory parameters for the risk of viruses coinfections among CAP. Binary logistic analysis was performed to test the association between various indexes and viruses co-infection.
RESULTS
RESULTS
Eighty-four multiple viruses coinfections yielded different prognosis compared with that in 220 single virus coinfection. CMV coinfection was associated with longest hospitalization days, highest ALT, AST and CKMB level. HSV coinfection was associated with highest WBC count, CRP, ESR, and BUN. EBV coinfection was associated with highest PLT and PCT level. FluB coinfection was associated with highest Scr level. CoxsV coinfection was associated with highest uRBC, LDH and CK level. ROC curve analyses showed that CK had the largest area under the curve (AUC: 0.672, p < 10
CONCLUSIONS
CONCLUSIONS
Multiple viruses coinfections indicated different prognosis. Different viruses coinfection yielded varying degrees of effects on the cardiac, liver, kidney and inflamatory injury in CAP. The alterations of clinical/laboratory parameters, particularly CK may be associated with the risk of viruses coinfections in CAP.
Identifiants
pubmed: 39014398
doi: 10.1186/s12887-024-04939-0
pii: 10.1186/s12887-024-04939-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
457Informations de copyright
© 2024. The Author(s).
Références
Niese R, van der Vlist D, Verhagen M, de Haan N, Stunnenberg M, Serafim F, Kretzschmar M, van der Wal A, Vermeulen L, Tholen A, de RodaHusman AM. Risk mapping of respiratory viral transmission and disease severity using individual and environmental health parameters: a scoping review and protocol analysis. One Health. 2024;18:100741.
doi: 10.1016/j.onehlt.2024.100741
pubmed: 38721143
pmcid: 11077019
Verma N, Awasthi S, Pandey AK, Gupta P. Association of Interleukin-1 Receptor Antagonist ( IL-1RA ) gene polymorphism with community-acquired pneumonia in north indian children: a case-control study. Glob Med Genet. 2023;10(2):109–16.
doi: 10.1055/s-0043-1770056
pubmed: 37332685
pmcid: 10275672
Green AE, Pottenger S, Monshi MS, Barton TE, Phelan M, Neill DR. Airway metabolic profiling during Streptococcus pneumoniae infection identifies branched chain amino acids as signatures of upper airway colonisation. PLoS Pathog. 2023;19(9):e1011630.
doi: 10.1371/journal.ppat.1011630
pubmed: 37669280
pmcid: 10503754
Jiang Z, Li S, Zhu C, Zhou R, Leung PHM. Mycoplasma pneumoniae Infections: pathogenesis and vaccine development. Pathogens. 2021;10(2):119.
doi: 10.3390/pathogens10020119
pubmed: 33503845
pmcid: 7911756
Wang H, Zhao M, Liu S, Wang X. Efficacy and safety of reduning injection combined with azithromycin in the treatment of mycoplasma pneumonia among children: a systematic review and meta-analysis. Phytomedicine. 2022;106:154402.
doi: 10.1016/j.phymed.2022.154402
pubmed: 36029644
Yun KW, Wallihan R, Juergensen A, Mejias A, Ramilo O. Community-acquired pneumonia in children: myths and facts. Am J Perinatol. 2019;36(S 02):S54–7.
doi: 10.1055/s-0039-1691801
pubmed: 31238360
Pratt MTG, Abdalla T, Richmond PC, Moore HC, Snelling TL, Blyth CC, Bhuiyan MU. Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(8):555–70.
doi: 10.1016/S2352-4642(22)00092-X
pubmed: 35636455
Baraldi E, Bonadies L, Manzoni P. Evidence on the link between respiratory syncytial virus infection in early life and chronic obstructive lung diseases. Am J Perinatol. 2020;37(S 02):S26–30.
doi: 10.1055/s-0040-1714345
pubmed: 32772357
Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D. Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021;21(1):127.
doi: 10.1186/s12887-021-02599-y
pubmed: 33722228
pmcid: 7958388
Hashemian SM, Farhadi T, Varahram M, Velayati AA. Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury. Expert Rev Anti Infect Ther. 2023;21(1):7–14.
doi: 10.1080/14787210.2023.2153116
pubmed: 36440472
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S. RSV prevention in all infants: which is the most preferable strategy? Front Immunol. 2022;13:880368.
doi: 10.3389/fimmu.2022.880368
pubmed: 35572550
pmcid: 9096079
Chen J, Zhao Y, Shang Y, Lin Z, Xu G, Bai B, Zheng J, Li P, Mao Y, Deng Q, Yu Z. The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe pneumonia. J Med Microbiol. 2021;70:001259:1-8.
Scott JA, Wonodi C, Moïsi JC, Deloria-Knoll M, DeLuca AN, Karron RA, Bhat N, Murdoch DR, Crawley J, Levine OS, O’Brien KL, Feikin DR. The definition of pneumonia, the assessment of severity, and clinical standardization in the pneumonia etiology research for child health study. Clin Infect Dis. 2012;2:S109–16.
doi: 10.1093/cid/cir1065
Smith DK, Kuckel DP, Recidoro AM. Community-acquired pneumonia in children: rapid evidence review. Am Fam Physician. 2021;104(6):618–25.
pubmed: 34913645
Dulek DE, Ardura MI, Green M, Michaels MG, Chaudhuri A, Vasquez L, Danziger-Isakov L, Posfay-Barbe KM, McCulloch MI, L’Huillier AG, Benden C. Update on COVID-19 vaccination in pediatric solid organ transplant recipients. Pediatr Transplant. 2022;26(5):e14235.
doi: 10.1111/petr.14235
pubmed: 35060251
Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787–821.
doi: 10.1146/annurev-immunol-032414-112326
pubmed: 25706097
Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72(10):651–8.
doi: 10.1136/jclinpath-2019-205822
pubmed: 31315893
Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, Shen M. Epidemiological characteristics of four common respiratory viral infections in children. Virol J. 2021;18(1):10.
doi: 10.1186/s12985-020-01475-y
pubmed: 33407659
pmcid: 7787583
Komura T, Kagaya T, Takayama H, Yanagi M, Yoshio T, Sugimoto S, Nishino M, Orita N, Asahina Y, Nishikawa M, Kaneko S, Unoura M. Clinical features and dynamics of T cells-related markers in immunocompetent patients with cytomegalovirus hepatitis. Can J Gastroenterol Hepatol. 2020;2020:8874620.
doi: 10.1155/2020/8874620
pubmed: 32908853
pmcid: 7477594
He L, Wang B, Li Y, Zhu L, Li P, Zou F, Bin L. The solute carrier transporter SLC15A3 participates in antiviral innate immune responses against herpes simplex virus-1. J Immunol Res. 2018;2018:5214187.
doi: 10.1155/2018/5214187
pubmed: 30069489
pmcid: 6057324
Wang Y, Zhuan X, Peng Y, Li Q, Huang C, Huang H, Liang Z, Wang Q, Chang J. In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3. Acta Virol. 2021;65(1):58–67.
doi: 10.4149/av_2021_106
pubmed: 33827222
Hu Z, Hu J, Hu S, Song Q, Ding P, Zhu J, Liu X, Wang X, Liu X. High levels of virus replication and an intense inflammatory response contribute to the severe pathology in lymphoid tissues caused by Newcastle disease virus genotype VIId. Arch Virol. 2015;160:639–48.
doi: 10.1007/s00705-014-2301-2
pubmed: 25504358
Chatzopoulou F, Gioula G, Kioumis I, Chatzidimitriou D, Exindari M. Identification of complement-related host genetic risk factors associated with influenza A(H1N1) pdm09 outcome: challenges ahead. Med Microbiol Immunol. 2019;208(5):631–40.
doi: 10.1007/s00430-018-0567-9
pubmed: 30306260